Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease

BACKGROUND: Effective SARS-CoV-2 vaccination in patients receiving treatment with B-cell depleting agents is challenging. Information on vaccination responses in these patients are a valuable tool to develop efficient vaccination regimens. METHODS: In this single-center retrospective observational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Frederic, Huzly, Daniela, Tanriver, Yakup, Welte, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472190/
https://www.ncbi.nlm.nih.gov/pubmed/36104663
http://dx.doi.org/10.1186/s12879-022-07722-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472190/
https://www.ncbi.nlm.nih.gov/pubmed/36104663
http://dx.doi.org/10.1186/s12879-022-07722-7

Ejemplares similares